| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Applications of Recombinant DNA Technology in the Production of Glycosylated Recombinant Human Granulocyte Colony Stimulating Factor
|
Holloway, C.J.
|
|
|
30 |
S3 |
p. S2-S6
|
artikel
|
| 2 |
Chemotherapy Dose Intensity Facilitated by Use of Lenograstim—Implications for Quality of Life and Survival
|
Gisselbrecht, C.
|
|
|
30 |
S3 |
p. S30-S33
|
artikel
|
| 3 |
European Journal of Cancer
|
|
|
|
30 |
S3 |
p. i
|
artikel
|
| 4 |
Evaluation of Haematopoietic Growth Factors: Defining Relevant Clinical Endpoints in Growth Factor Trials
|
Linch, D.C.
|
|
|
30 |
S3 |
p. S40-S43
|
artikel
|
| 5 |
Future Strategy for Cancer Treatment Using Recombinant Human Granulocyte Colony Stimulating Factor
|
Diehl, V.
|
|
|
30 |
S3 |
p. S44-S47
|
artikel
|
| 6 |
Glycosylation of Recombinant Human Granulocyte Colony Stimulating Factor: Implications for Stability and Potency
|
Nissen, C.
|
|
|
30 |
S3 |
p. S12-S14
|
artikel
|
| 7 |
Granulocyte Colony Stimulating Factor: From Laboratory Bench to Clinical Use
|
Dexter, T.M.
|
|
|
30 |
S3 |
p. S15-S19
|
artikel
|
| 8 |
Introduction
|
Bonadonna, G.
|
|
|
30 |
S3 |
p. S1
|
artikel
|
| 9 |
Physicochemical and Biochemical Characteristics of Glycosylated Recombinant Human Granulocyte Colony Stimulating Factor (Lenograstim)
|
Ono, M.
|
|
|
30 |
S3 |
p. S7-S11
|
artikel
|
| 10 |
The Changing Face of Stem Cell Transplantation by the Use of Recombinant Human Granulocyte Colony Stimulating Factor
|
Boogaerts, M.A.
|
|
|
30 |
S3 |
p. S34-S39
|
artikel
|
| 11 |
The Clinical Benefits of Recombinant Human Granulocyte Colony Stimulating Factor in the Treatment of Cancer Patients
|
Bacigalupo, A.
|
|
|
30 |
S3 |
p. S26-S29
|
artikel
|
| 12 |
The Optimal Dose of Glycosylated Recombinant Human Granulocyte Colony Stimulating Factor for Use in Clinical Practice: A Review
|
Marty, M.
|
|
|
30 |
S3 |
p. S20-S25
|
artikel
|
Tijdschrift beschrijving